(Q43572266)

English

Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone

scientific article published in March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone (English)

1 reference

Europe PubMed Central

24 November 2017

author name string

Navarro JT

1

1 reference

Europe PubMed Central

24 November 2017

Ribera JM

2

1 reference

Europe PubMed Central

24 November 2017

Oriol A

3

1 reference

Europe PubMed Central

24 November 2017

Vaquero M

4

1 reference

Europe PubMed Central

24 November 2017

Romeu J

5

1 reference

Europe PubMed Central

24 November 2017

Batlle M

6

1 reference

Europe PubMed Central

24 November 2017

Flores A

7

1 reference

Europe PubMed Central

24 November 2017

Millá F

8

1 reference

Europe PubMed Central

24 November 2017

Feliu E

9

1 reference

Europe PubMed Central

24 November 2017

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

24 November 2017

British Journal of Haematology

1 reference

Europe PubMed Central

24 November 2017

112

1 reference

Europe PubMed Central

24 November 2017

4

1 reference

Europe PubMed Central

24 November 2017

909-915

1 reference

Europe PubMed Central

24 November 2017

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02656.X

21 January 2018

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02656.X

21 January 2018

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02656.X

21 January 2018

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02656.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02656.X

21 January 2018

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02656.X

21 January 2018

352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02656.X

21 January 2018

Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus: Aquitaine Cohort, France, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02656.X

21 January 2018

Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02656.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2001.02656.X

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43572266&oldid=2101204980"